• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Steven L. Chang, MD

Publications

  • Gandaglia G, Sammon JD, Chang SL, Choueiri TK, Hu JC, Karakiewicz PI, Kibel AS, Kim SP, Konijeti R, Montorsi F, Nguyen PL, Sukumar S, Menon M, Sun M, Trinh QD.Comparative Effectiveness of Robot-Assisted and Open Radical Prostatectomy in the Postdissemination Era.J Clin Oncol. 2014 Apr 14.
    24733797
  • Leow JJ, Martin-Doyle W, Fay AP, Choueiri TK, Chang SL, Bellmunt J.A Systematic Review and Meta-analysis of Adjuvant and Neoadjuvant Chemotherapy for Upper Tract Urothelial Carcinoma.Eur Urol. 2014 Mar 16.
    24680361
  • Leow JJ, Reese S, Trinh QD, Bellmunt J, Chung BI, Kibel AS, Chang SL.The Impact of Surgeon Volume on the Morbidity and Costs of Radical Cystectomy in the United States: A Contemporary Population-Based Analysis.BJU Int. 2014 Mar 27.
    24674655
  • Bhojani N, Gandaglia G, Sood A, Rai A, Pucheril D, Chang SL, Karakiewicz PI, Menon M, Olugbade K, Ruhotina N, Sammon JD, Sukumar S, Sun M, Ghani KR, Schmid M, Varda B, Kibel AS, Zorn KC, Trinh QD.Morbidity and Mortality After Benign Prostatic Hyperplasia Surgery: Data from the American College of Surgeons National Surgical Quality Improvement Program.J Endourol. 2014 Mar 12.
    24517323
  • Shinagare AB, Silverman SG, Gershanik EF, Chang SL, Khorasani R.Evaluating Hematuria: Impact of Guideline Adherence on Urologic Cancer Diagnosis.Am J Med. 2014 Feb 21.
    24565590
  • Leow JJ, Reese SW, Jiang W, Lipsitz SR, Bellmunt J, Trinh QD, Chung BI, Kibel AS, Chang SL.Propensity-Matched Comparison of Morbidity and Costs of Open and Robot-Assisted Radical Cystectomies: A Contemporary Population-Based Analysis in the United States.Eur Urol. 2014 Jan 28.
    24491306
  • Look Hong NJ, Chang SL, Raut CP.The economic impact of cytoreductive surgery and tyrosine kinase inhibitor therapy in the treatment of advanced gastrointestinal stromal tumours: a Markov chain decision analysis.Eur J Cancer. 2014 Jan;50(2):397-405.
    24215847
  • Antczak C, Trinh VQ, Sood A, Ravi P, Roghmann F, Trudeau V, Chang SL, Karakiewicz PI, Kibel AS, Krishna N, Nguyen PL, Saad F, Sammon JD, Sukumar S, Zorn KC, Sun M, Trinh QD.The health care burden of skeletal-related events in renal cell carcinoma patients with bone metastases.J Urol. 2013 Dec 30.
    24384157
  • Leow JJ, Martin-Doyle W, Rajagopal PS, Patel CG, Anderson EM, Rothman AT, Cote RJ, Urun Y, Chang SL, Choueiri TK, Bellmunt J.Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials.Eur Urol. 2013 Aug 28.
    24018020
  • Chang SL, Cipriano LE, Harshman LC, Garber AM, Chung BI.Cost-effectiveness analysis of nephron sparing options for the management of small renal masses.J Urol. 2011 May;185(5):1591-7.
    21419445
  • Hsu M, Chang SL, Ferrari M, Nolley R, Presti Jr JC, Brooks JD.Length of site-specific positive surgical margins as a risk factor for biochemical recurrence following radical prostatectomy.Int J Urol. 2011 Feb 22.
    21342296
  • Chang SL, Harshman LC, Presti JC.Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and Nutrition Examination Survey.J Clin Oncol. 2010 Sep 1;28(25):3951-7.
    20679596
  • Levesque BG, Cipriano LE, Chang SL, Lee KK, Owens DK, Garber AM.Cost effectiveness of alternative imaging strategies for the diagnosis of small-bowel Crohn's disease.Clin Gastroenterol Hepatol. 2010 Mar;8(3):261-7, 267.e1-4.
    19896559
  • Chang SL, Freedland SJ, Terris MK, Aronson WJ, Kane CJ, Amling CL, Presti JC.Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH database.Urology. 2010 Feb;75(2):439-44.
    19819536
  • Chang SL, Gonzalgo ML.Editorial comment.J Urol. 2010 Feb;183(2):459; discussion 459.
    20006881
  • Chang SL, Gonzalgo ML.Surgery: laparoscopic prostatectomy: learning curve and cancer control.Nat Rev Urol. 2009 Jul;6(7):361-2.
    19578354
  • Chang SL, Liao JC, Shinghal R.Decreasing use of luteinizing hormone-releasing hormone agonists in the United States is Independent of Reimbursement Changes: A Medicare and Veterans Health Administration claims analysis.J Urol. 2009 Jul;182(1):255-60; discussion 261.
    19450844